Personalised medicine biomarkers market to hit $58.4b by 2032 | Healthcare Asia Magazine
Photo from Envato

Personalised medicine biomarkers market to hit $58.4b by 2032

Thanks to the rising demand for targeted therapies.

The global personalised medicine biomarkers market is projected to reach $58.4b by 2032 at a compound annual growth rate of 14.54%, according to SNS Insider pvt ltd.

The sector’s expansion is attributed to the rising demand for targeted therapies, the need for early disease detection, and the emergence of novel biomarkers that allow for personalised treatment strategies.

Meanwhile, key developments include next-generation sequencing, proteomics, and bioinformatics.

Moreover, government initiatives and funding for research are further driving the market’s growth.

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Aster Sanad Hospital to expand specialised care
Its CEO plans to boost centers of excellence in cardiology, orthopaedics, and neurology.
Healthcare
Hospitals need unified strategy vs ransomware
Healthcare was the second-most attacked sector by ransomware in the first half of 2024.
UTAR Hospital’s Ding Lay Ming pushes specialist rural care
The not-for-profit hospital's CEO wants to reach the poor whilst also serving those who can pay.